We are live on ! Find out more
SPHS

Sophiris Bio, Inc.
SPHS

Delisted

SPHS was delisted on the 11th of March, 2020.

16 hedge funds and large institutions have $1.09M invested in Sophiris Bio, Inc. in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

14% more funds holding

Funds holding: 1416 (+2)

9% more capital invested

Capital invested by funds: $998K → $1.09M (+$89K)

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change

SPHS Hedge Fund Activity: Q1 2015 in Review

16 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q1 2015, worth a combined $1.09M — up 8.9% from $998K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new SPHS positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Gruss Capital Management, adding an estimated $26.2K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $33K sold.

  • 16 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q1 2015, up from 14 in Q4 2014.
  • Funds reported $1.09M of Sophiris Bio, Inc. stock for Q1 2015, up 8.9% quarter-over-quarter.
  • 3 funds opened new Sophiris Bio, Inc. positions in Q1 2015 and 1 closed out, a net change of +2 holders.
  • The largest Sophiris Bio, Inc. buyer in Q1 2015 was Gruss Capital Management, an estimated $26.2K added.
  • The largest Sophiris Bio, Inc. seller in Q1 2015 was Virtu KCG Holdings, an estimated $33K sold.

Based on aggregated 13F filings for Q1 2015.